As immuno-oncology treatment modalities such as checkpoint inhibitors and cancer vaccines evolve, understanding how the immune system responds to these therapies is critical. Immunogenicity and immunotoxicity assays are essential for profiling tumor-immune interactions, optimizing therapeutic efficacy, and ensuring drug safety. In this webinar, Ethan Shelkey and Aurita Menezes will discuss practical examples and strategies for using cell-based assays to assess immune activation, offering actionable insights for advancing cancer immunotherapy development.
Topics to be covered
- Designing and applying cell-based assays for immuno-oncology research
- Key primary cell-based assays for measuring immunogenicity and immunotoxicity
- Key considerations for using donor diversity in drug testing
Tuesday, March 11th, 2025 | 11:00 AM - 12:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers

Ethan Shelkey, PhD
Research Scientist
Lonza

Aurita Menezes, PhD
Senior Market Development Manager
Lonza